Registration number: SC761695

Liver Scan Group Limited

Contents

Company Information	1
Balance Sheet	2
Notes to the Unaudited Financial Statements	3 to 5

Liver Scan Group Limited

Company Information

Directors

Mr Bruce Smith Anderson Ms Claire Hardie Mr Ian James Gray Mr Christopher St Clair Ross Professor Walter Sneddon Nimmo

Registered office

44 Charlotte Square Edinburgh EH2 4HQ

Accountants

JS Accounting Services Ltd 13-15 Morningside Drive Edinburgh EH10 5LZ

Liver Scan Group Limited

(Registration number: SC761695)
Balance Sheet as at 31 May 2025

	Note	2025 £	2024 £
Fixed assets
Tangible assets	3	12,968	18,094
Current assets
Debtors	4	12,601	13,966
Cash at bank and in hand		43,343	65,082
		55,944	79,048
Creditors: Amounts falling due within one year		(2,999)	(8,534)
Net current assets		52,945	70,514
Net assets		65,913	88,608
Capital and reserves
Called up share capital		136	136
Share premium reserve		309,874	249,872
Retained earnings		(244,097)	(161,400)
Shareholders' funds		65,913	88,608

For the financial year ending 31 May 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' responsibilities:

•	The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476; and
•	The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime. As permitted by section 444 (5A) of the Companies Act 2006, the directors have not delivered to the registrar a copy of the Profit and Loss Account.

Approved and authorised by the Board on 24 October 2025 and signed on its behalf by:
 

......................................... Mr Bruce Smith Anderson Director

Liver Scan Group Limited

Notes to the Unaudited Financial Statements for the Year Ended 31 May 2025

1	Accounting policies

Summary of significant accounting policies and key accounting estimates

The principal accounting policies applied in the preparation of these financial statements are set out below. These policies have been consistently applied to all the years presented, unless otherwise stated.

Statement of compliance

These financial statements have been prepared in accordance with Financial Reporting Standard 102 Section 1A smaller entities - 'The Financial Reporting Standard applicable in the United Kingdom and Republic of Ireland' and the Companies Act 2006 (as applicable to companies subject to the small companies' regime).

Basis of preparation

These financial statements have been prepared using the historical cost convention except that as disclosed in the accounting policies certain items are shown at fair value.

Revenue recognition

Turnover comprises the fair value of the consideration received or receivable for the sale of goods and provision of services in the ordinary course of the company’s activities. Turnover is shown net of sales/value added tax, returns, rebates and discounts.

The company recognises revenue when:
The amount of revenue can be reliably measured;
it is probable that future economic benefits will flow to the entity;
and specific criteria have been met for each of the company's activities.

Tangible assets

Tangible assets are stated in the balance sheet at cost, less any subsequent accumulated depreciation and subsequent accumulated impairment losses.

The cost of tangible assets includes directly attributable incremental costs incurred in their acquisition and installation.

Depreciation

Depreciation is charged so as to write off the cost of assets, other than land and properties under construction over their estimated useful lives, as follows:

Cash and cash equivalents

Cash and cash equivalents comprise cash on hand and call deposits, and other short-term highly liquid investments that are readily convertible to a known amount of cash and are subject to an insignificant risk of change in value.

Trade debtors

Trade debtors are amounts due from customers for merchandise sold or services performed in the ordinary course of business.

Trade debtors are recognised initially at the transaction price. They are subsequently measured at amortised cost using the effective interest method, less provision for impairment. A provision for the impairment of trade debtors is established when there is objective evidence that the company will not be able to collect all amounts due according to the original terms of the receivables.

Liver Scan Group Limited

Notes to the Unaudited Financial Statements for the Year Ended 31 May 2025

Trade creditors

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Accounts payable are classified as current liabilities if the company does not have an unconditional right, at the end of the reporting period, to defer settlement of the creditor for at least twelve months after the reporting date. If there is an unconditional right to defer settlement for at least twelve months after the reporting date, they are presented as non-current liabilities.

Trade creditors are recognised initially at the transaction price and subsequently measured at amortised cost using the effective interest method.

Leases

Leases in which substantially all the risks and rewards of ownership are retained by the lessor are classified as operating leases. Payments made under operating leases are charged to profit or loss on a straight-line basis over the period of the lease.

Share capital

Ordinary shares are classified as equity. Equity instruments are measured at the fair value of the cash or other resources received or receivable, net of the direct costs of issuing the equity instruments. If payment is deferred and the time value of money is material, the initial measurement is on a present value basis.

2	Staff numbers

The average number of persons employed by the company (including directors) during the year, was 2 (2024 - 2).

3	Tangible assets

	Land and buildings £	Fixtures and fittings £	Plant and machinery £	Office equipment £
Cost or valuation
At 1 June 2024	8,206	12,592	370	2,052
At 31 May 2025	8,206	12,592	370	2,052
Depreciation
At 1 June 2024	1,641	2,891	92	502
Charge for the year	1,641	2,891	92	502
At 31 May 2025	3,282	5,782	184	1,004
Carrying amount
At 31 May 2025	4,924	6,810	186	1,048
At 31 May 2024	6,565	9,701	278	1,550

Liver Scan Group Limited

Notes to the Unaudited Financial Statements for the Year Ended 31 May 2025

	Total £
Cost or valuation
At 1 June 2024	23,220
At 31 May 2025	23,220
Depreciation
At 1 June 2024	5,126
Charge for the year	5,126
At 31 May 2025	10,252
Carrying amount
At 31 May 2025	12,968
At 31 May 2024	18,094

Included within the net book value of land and buildings above is £4,924 (2024 - £6,565) in respect of freehold land and buildings and £Nil (2024 - £Nil) in respect of short leasehold land and buildings.
 

4

Debtors

Current	2025 £	2024 £
Prepayments	12,601	12,601
Other debtors	-	1,365
	12,601	13,966